BPMC : Insider Transactions for Blueprint Medicines Corp | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Blueprint Medicines Corp (BPMC)

$105.56

0.80 (0.75%) as of 4:30 Fri 5/31

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

66,002,000

Market Cap:

6.97(B)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$43.96 - $108.78

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : 486

Guru Rank Value : 3

Guru Occurances : 1


6 Months 1 Year 2 Year

Company Profile Blueprint Medicines is a precision therapy company that is inventing medicines for people with cancer and blood disorders. Co. is delivering ITS approved medicines, AYVAKIT®/AYVAKYT® (avapritinib) and GAVRETO® (pralsetinib), to patients in the U.S. and Europe, and Co. is globally developing various programs for systemic mastocytosis lung cancer and other genomically defined cancers, and cancer immunotherapy. Co.'s drug discovery approach combines its biological insights with its proprietary compound library and chemistry capabilities to design therapies, with the goal of delivering clinical benefit to patients based on the genetic driver of their disease.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	1,100
Total Buy Value	$0	$0	$0	$48,378
Total People Bought	0	0	0	1
Total Buy Transactions	0	0	0	1
Total Shares Sold	140,074	185,302	263,382	381,554
Total Sell Value	$12,910,702	$16,666,116	$20,928,894	$27,757,920
Total People Sold	12	12	12	12
Total Sell Transactions	22	29	39	64
End Date	2024-03-03	2023-12-01	2023-06-02	2022-06-02

Adjust Filter Settings

Records found: 565

Page 20 of 23

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Director

– • –

2018-02-14

4

AS

$80.42

$1,005,250

D/D

(12,500)

174,342

-

Director

– • –

2018-02-12

4

AS

$73.27

$1,309,668

D/D

(17,500)

186,842

-

Chief Business Officer

• – –

2018-02-12

4

AS

$72.64

$507,619

D/D

(6,775)

5,874

-

Chief Business Officer

• – –

2018-02-12

4

OE

$16.28

$110,297

D/D

6,775

12,649

-

Chief Scientific Officer

• – –

2017-11-22

4

AS

$70.00

$641,620

D/D

(9,166)

0

-

Chief Scientific Officer

• – –

2017-11-22

4

OE

$37.11

$340,150

D/D

9,166

9,166

-

Chief Scientific Officer

• – –

2017-11-21

4/A

AS

$64.44

$32,220

D/D

(500)

0

-

Chief Business Officer

• – –

2017-11-21

4

OE

$16.28

$95,629

D/D

5,874

5,874

-

Chief Scientific Officer

• – –

2017-11-21

4

S

$64.44

$32,220

D/D

(500)

0

-

Chief Scientific Officer

• – –

2017-11-21

4

AS

$65.16

$1,167,793

D/D

(17,834)

500

-

Chief Scientific Officer

• – –

2017-11-21

4

OE

$37.11

$680,375

D/D

18,334

18,334

-

Director

– • –

2017-11-15

4

AS

$62.59

$316,898

D/D

(5,000)

204,342

-

Albers Jeffrey W.

CEO and President

• • –

2017-11-06

4

AS

$68.95

$2,109,251

D/D

(30,000)

0

-

Albers Jeffrey W.

CEO and President

• • –

2017-11-06

4

OE

$1.87

$45,841

D/D

24,514

30,000

-

Boral Anthony L.

Chief Medical Officer

• – –

2017-11-06

4

AS

$69.59

$352,022

D/D

(5,000)

0

-

Boral Anthony L.

Chief Medical Officer

• – –

2017-11-06

4

OE

$8.80

$44,000

D/D

5,000

5,000

-

Chief Business Officer

• – –

2017-10-05

4

AS

$65.45

$362,033

D/D

(5,449)

0

-

Chief Business Officer

• – –

2017-10-05

4

OE

$16.28

$88,710

D/D

5,449

5,449

-

Chief Business Officer

• – –

2017-09-18

4

AS

$60.03

$381,551

D/D

(6,356)

0

-

Chief Business Officer

• – –

2017-09-18

4

OE

$16.28

$103,476

D/D

6,356

6,356

-

Director

– • –

2017-09-18

4

AS

$60.00

$150,000

D/D

(2,500)

209,342

-

Boral Anthony L.

Chief Medical Officer

• – –

2017-08-09

4

AS

$47.79

$242,986

D/D

(5,000)

0

-

Boral Anthony L.

Chief Medical Officer

• – –

2017-08-09

4

OE

$8.80

$44,000

D/D

5,000

5,000

-

Albers Jeffrey W.

CEO and President

• • –

2017-08-08

4

AS

$50.70

$507,000

D/D

(10,000)

5,486

-

Albers Jeffrey W.

CEO and President

• • –

2017-08-07

4

AS

$48.29

$981,637

D/D

(20,000)

15,486

-

565 Records found	Previous 20 21 22 23	Page 20 of 23

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.